Kenneth Khaw, MD
Interventional Cardiology · Hammonton, NJNPI 1336119601
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $12,734 of the $19,647 with a category attached, or 64.8%. 36 manufacturers reported payments, led by Medtronic at 29.7% of the total. 2025 is the largest year on record at $5,322, 8.8 times the $604 reported in 2019.
Across 424 payments — averaging $46.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$6K
- Boston Scientific$3K
- Penumbra, Inc.$2K
- AstraZeneca$2K
- Abiomed$902
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$863
- plus $6K from 30 others
What the payments were for
- Travel & lodging$6,90735%
- Food & beverage$12,73465%
- Education$60%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 49 | $5,834 |
| Boston Scientific | 41 | $2,675 |
| Penumbra, Inc. | 6 | $1,654 |
| AstraZeneca | 37 | $1,594 |
| Abiomed | 21 | $902 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 49 | $863 |
| E.r. Squibb & Sons, L.L.C. | 33 | $741 |
| Johnson & Johnson | 25 | $662 |
| Stryker | 4 | $643 |
| Pfizer | 15 | $503 |
| Shockwave Medical, Inc | 16 | $450 |
| Philips North America LLC | 31 | $419 |
| Merck | 19 | $367 |
| Novartis | 20 | $358 |
| Abbott | 7 | $292 |
| Inari Medical, Inc. | 4 | $285 |
| Boehringer Ingelheim | 7 | $207 |
| Sanofi-aventis U.S. LLC | 5 | $176 |
| Impulse Dynamics (USA) Inc. | 2 | $150 |
| Sunovion Pharmaceuticals Inc. | 1 | $117 |
| Chiesi USA, Inc. | 2 | $116 |
| Edwards Lifesciences | 1 | $108 |
| Cardiovascular Systems Inc. | 4 | $84 |
| Cardinal Health 200 LLC | 4 | $55 |
| Esperion Therapeutics, Inc. | 4 | $54 |
| Terumo Medical Corporation | 2 | $43 |
| Scpharmaceuticals Inc. | 2 | $37 |
| Asahi Intecc USA, Inc. | 1 | $36 |
| Kestra Medical Technology Services, Inc. | 1 | $36 |
| Bayer | 2 | $36 |
| Angiodynamics, Inc. | 2 | $34 |
| W. L. Gore & Associates, Inc. | 2 | $34 |
| Novo Nordisk | 2 | $29 |
| Cardiva Medical, Inc. | 1 | $21 |
| Alnylam Pharmaceuticals Inc. | 1 | $17 |
| Kiniksa Pharmaceuticals International, PLC | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- WATCHMAN Access System$1,744
- Resolute$1,655
- Indigo System$1,558
- FARXIGA$818
- CLOTTRIEVER BOLD CATHETER$600
- BRILINTA$352
- CAMZYOS$259
- OPTIMIZER$247
- VERQUVO$232
- WAINUA$225
- ONYX FRONTIER$137
- VYNDAQEL$128
- WATCHMAN FLX$125
- XARELTO$125
- LONHALA MAGNAIR$117
- AVVIGO Guidance System$117
- Edwards SAPIEN 3 Ultra Transcatheter Heart Valve$108
- FLOWTRIEVER CATHETER, S$108
- CT THROMBECTOMY SYSTEM KIT$108
- LOKELMA$103
How this compares
$19,647 in reported general payments places this provider in the 75th percentile of 166 interventional cardiology providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EntrestoSacubitril/Valsartan | 19 | $33,932 |
| XareltoRivaroxaban | 24 | $32,743 |
| EliquisApixaban | 24 | $17,152 |
| JardianceEmpagliflozin | 11 | $6,611 |
| Ranolazine ErRanolazine | 15 | $815 |
| Rosuvastatin Calcium | 29 | $590 |
| Atorvastatin Calcium | 20 | $249 |
| Amlodipine Besylate | 43 | $232 |
| Cilostazol | 15 | $214 |
| Isosorbide Mononitrate ErIsosorbide Mononitrate | 21 | $186 |
| Metoprolol Succinate | 14 | $150 |
| Triamterene-HydrochlorothiazidTriamterene/Hydrochlorothiazid | 19 | $146 |
| Losartan Potassium | 13 | $127 |
| Metoprolol Tartrate | 14 | $98 |
| Furosemide | 18 | $98 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| NovartisEntresto | $358 | $33,93219 claims |
| Johnson & JohnsonXarelto | $662 | $32,74324 claims |
| PfizerEliquis | $503 | $17,15224 claims |
| Boehringer IngelheimJardiance | $207 | $6,61111 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 166 interventional cardiology providers in New Jersey.
Other interventional cardiology in Hammonton
- Ankitkumar PatelGlen Ridge$408K
- Ziad AbbudOcean$360K
- Ramin HastingsHasbrouck Heights$295K
- Michael LimHackensack$215K
- Darshan GodkarCedar Knolls$194K
- Ryan KapleHackensack$178K
- Matthew SayboltEatontown$175K
- Daniel KissEatontown$172K
- Kintur SanghviBordentown$139K
- Dimitrios KarmpaliotisMorristown$129K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.